Lithera, a US-based drugs company for abdominal swelling, has raised $20.6m from a consortium including South Korea-based cosmetics maker AmorePacific and clinical trial information and logistics services provider Numoda’s corporate venturing units. The round might increase to $35.6m if performance targets are met. The deal is AmorePacific Ventures’ first public investment since being formally set…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
